Risks involved in retinal gene theraphy
RISKS INVOLVED IN RETINAL GENE THERAPY – BIOETHICAL CONSIDERATIONS Jelena Bućan*, Kajo Bućan* Jelena Bućan, Research Assistant at University Department of Forensic Sciences Split, univ.mag.rel.int. / mag.educ.philol.angl. et ital. prof. Kajo Bućan, MD, PhD, ophthalmologist, president of Retinal Section of Croatian Ophthalmological Society; regular member